Sionna Therapeutics宣布,该公司正在开发用于治疗囊胞性纤维化的专有双重组合疗法中,评估Nbd1稳定剂Sion-451的1期临床试验已对首批受试者完成给药。
Sionna Therapeutics宣布,该公司正在开发用于治疗囊胞性纤维化的专有双重组合疗法中,评估Nbd1稳定剂Sion-451的1期临床试验已对首批受试者完成给药。
Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.